Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
104 hedge funds and large institutions have $444M invested in Taro Pharmaceutical Industries Ltd. in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 35 reducing their positions, and 10 closing their positions.
100% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 10
33% more capital invested
Capital invested by funds: $333M → $444M (+$111M)
11% more funds holding
Funds holding: 94 → 104 (+10)
17% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 35
32% less call options, than puts
Call options by funds: $227K | Put options by funds: $335K
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$5.71M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$5.35M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.16M |
| 4 |
Renaissance Technologies
New York
|
+$4.63M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$4.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FL
Fort LP
Chevy Chase,
Maryland
|
-$6.27M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.17M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$4.04M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.5M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.42M |
TARO Hedge Fund Activity: Q1 2019 in Review
104 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q1 2019, worth a combined $444M — up 33% from $333M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new TARO positions and 10 closed out — a net gain of 10 holders — while 29 added to existing stakes and 35 trimmed.
The largest buyer was Hotchkis & Wiley Capital Management, opening a new position worth an estimated $5.71M. The largest seller was Fort LP, cutting an estimated $6.27M.
- 104 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q1 2019, up from 94 in Q4 2018.
- Funds reported $444M of Taro Pharmaceutical Industries Ltd. stock for Q1 2019, up 33% quarter-over-quarter.
- 20 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q1 2019 and 10 closed out, a net change of +10 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q1 2019 was Hotchkis & Wiley Capital Management, an estimated $5.71M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q1 2019 was Fort LP, an estimated $6.27M sold.
Based on aggregated 13F filings for Q1 2019.